NPCE logo

NeuroPace Inc

NPCE

Build a strategy around NPCE

Accountable AI Logo

NeuroPace Inc AI Insights

Informational only. Not investment advice.
As of 2026-02-20

Snapshot

  • Gross margin 76.8% TTM vs industry median 35% - 2.2x advantage reflects proprietary neuromodulation technology pricing power.[Gross Margin TTM]
  • Debt/equity 3.84x with 71.2M total debt against 18.5M equity - interest expense (8M TTM) consumes 8.5% of revenue.[Debt to Equity]
  • FCF burn of -16.6M TTM with only 20.6M cash - under 15 months runway at current rate without financing.[Free Cash Flow TTM]

Watch Triggers

  • Cash and Equivalents: Falls below 15MSignals imminent dilutive raise; watch quarterly burn rate vs cash position.
  • Total Revenue TTM: Exceeds 110M with stable opexBreakeven inflection point - operating leverage kicks in above this threshold.
  • Gross Margin TTM: Drops below 70%Pricing power erosion would extend path to profitability significantly.

Bull Case

Premium gross margins (77% vs 35% median) with minimal capex suggest high operating leverage - each incremental dollar flows 77 cents to opex coverage.

Gross Margin TTMCapital Expenditure TTM

Working capital of 75.7M (80% of assets) provides operational buffer; current ratio 4.9x indicates no near-term liquidity crisis.

Working CapitalCurrent Assets

Bear Case

Cash burn trajectory unsustainable: -16.6M FCF TTM against 20.6M cash implies dilutive financing within 12-15 months.

Free Cash Flow TTMCash and Equivalents

Leverage risk acute: 3.84x debt/equity with 8M annual interest on 95M revenue - covenant breach or refinancing risk if growth stalls.

Debt to EquityInterest Expense TTM

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
35%

Leverage NPCE's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Path to profitability hinges on revenue scaling past ~120M while maintaining 77% gross margins.

1-3ymed
  • Operating expense of 91M TTM is fixed-cost heavy (R&D 27M, S&M 13M)
  • Gross profit 72.8M already covers 80% of opex
  • Minimal capex needs (274K TTM) preserves margin flow-through
Operating margin -19% vs gross margin 77% gapR&D 28% of revenue indicates growth investment phaseAsset turnover 0.93x near industry median 0.91x

Valuation Context

Caveats

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2026 Accountable Finance, Inc. All rights reserved.